Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover pharmacokinetic study of CHF 1535 vs free combination of beclometasone and formoterol in asthmatic children
2011-001208-36Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone dipropionate + formoterol in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Plasma AUC0-t for B17MP. Started Aug 2011; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-001208-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001208-36.